Synchronized release of Doxil and Nutlin-3 by remote degradation of polysaccharide matrices and its possible use in the local treatment of colorectal cancer

Author： Nadler-Milbauer Mirela   Apter Lior   Haupt Ygal   Haupt Sue   Barenholz Yechezkel   Minko Tamara   Rubinstein Abraham  

Publisher： Informa Healthcare

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.19, Iss.10, 2011-12, pp. : 859-873

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Capecitabine: A Review of its Use in the Treatment of Advanced or Metastatic Colorectal Cancer

By McGavin J.K.   Goa K.L.  

Drugs, Vol. 61, Iss. 15, 2001-01 ,pp. : 2309-2326

Adis International

Access to resources Recommend Favorite

Bevacizumab: A Review of its Use in Metastatic Colorectal Cancer

By McCormack Paul L.   Keam Susan J.  

Drugs, Vol. 68, Iss. 4, 2008-01 ,pp. : 487-506

Adis International

Access to resources Recommend Favorite

A review of oxaliplatin and its clinical use in colorectal cancer

By Grothey Axel   Goldberg Richard M  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2159-2170

Informa Healthcare

Access to resources Recommend Favorite

Panitumumab: a guide to its use in metastatic colorectal cancer

By Keating Gillian M.  

Drugs & Therapy Perspectives, Vol. 28, Iss. 7, 2012-07 ,pp. : 6-9

Adis International

Access to resources Recommend Favorite

Panitumumab: A Review of its Use in Metastatic Colorectal Cancer

By Keating Gillian M.  

Drugs, Vol. 70, Iss. 8, 2010-05 ,pp. : 1059-1078

Adis International

Access to resources Recommend Favorite